North America Kidney Transplant Market will increase by around US$ 14.76 Billion by 2027. A kidney transplant is a surgical surgery that a healthy kidney is used to replace a damaged or sick kidney donated by another person. The goal of the transplant is to improve or restore the function of the recipient's kidneys, allowing them to live healthier lives with less dependence on dialysis. The success of a kidney transplant is dependent on various factors, including donor-recipient compatibility, good post-operative care, and the recipient's overall health.The North American Kidney Transplant Market was at US$ 11.36 Billion in 2022
In the United States and Canada, there is a large population of individuals with kidney disease, and a significant portion of these individuals require dialysis or a kidney transplant to manage their condition. A kidney transplant can offer these individuals a better quality of life, increased lifespan, and improved health outcomes compared to relying on dialysis alone. Additionally, the availability of advanced medical technology and skilled medical professionals in North American countries make kidney transplantation a safe and effective option for eligible patients. According to our study, the number of kidney transplants in 2022 will be 30.67 thousand, rising to 39.44 thousand by 2027.
North America Kidney Transplant Market will grow at a CAGR of 5.37% during the Forecast Period
Growing demand for kidney transplantation is also one of the key drivers driving expansion potential in the North American sector in the next years. A kidney transplant is reliant on a variety of variables and circumstances. These disorders include renal failure caused by several factors, such as acute dehydration and kidney damage.The unexpected spike in COVID-19 cases is also expected to raise demand for PPE kits and gloves in North America. Governments from all across the world have taken several initiatives to combat the spread of the new coronavirus. However, the installation of the lockdown has caused global disruptions in the manufacture, distribution, and delivery of medical supplies. Furthermore, health and clinic centers have declined drastically in recent years in order to preserve social distance. These issues will most likely restrict development opportunities in the kidney transplant industry in the next few years.
According to the (OPTN) Organ Procurement and Transplantation Network, 42,887 organ transplants will be done in the United States in 2022, a 3.7% increase over 2021. In addition, for the first time, over 25,000 kidney transplants were done in the United States. The number of 25,498 represented a 3.4 percent increase over 2021. Furthermore, factors such as increased public awareness of organ donation, the development of healthcare infrastructure, and the implementation of favorable reimbursement policies will contribute to the market's growth.
However, problems such as high transplantation costs and lengthy wait times are important impediments to the expansion of the North American kidney transplant industry. Nevertheless, the report shows that the North American kidney transplant market was at US$ 11.36 Billion in 2022.
By Region: The United States captured the Highest Market Share
The North American Kidney Transplant Market is divided into; the United States, Mexico, and Canada. In the United States and Canada, there is a large population of individuals with kidney disease, and a significant portion of these individuals require dialysis or a kidney transplant to manage their condition. A kidney transplant can offer these individuals a better quality of life, increased lifespan, and improved health outcomes compared to relying on dialysis alone. Additionally, the availability of advanced medical technology and skilled medical professionals in North American countries make kidney transplantation a safe and effective option for eligible patients.By Type: The Living Donor Transplant Market will rise in the Foreseeable Years
Based on types, the North American market is segmented into; deceased donor transplants and living donor transplants. The living donor transplant segment is forecasted to grow at a significant rate. As the living donor transplant takes place sooner, the kidney has fewer chances of rejection and lasts longer (15-20 years on average).By Drugs: The Calcineurin Inhibitors Revenue will grow due to Advancement and Technology in the Healthcare Industry
The Drugs categorizes into; calcineurin inhibitors, antiproliferative agents, mTOR inhibitors, steroids, and antibodies. Calcineurin inhibitors are a class of immunosuppressive drugs used in the management of organ transplantation, including kidney transplantation, in North American countries. These drugs help prevent the rejection of the transplanted organ by suppressing the immune system's response to the foreign tissue. The two most commonly used calcineurin inhibitors in North America are Cyclosporine and Tacrolimus. Both drugs are highly effective in preventing rejection, but they have different side-effect profiles and dosing requirements. These drugs are administered orally or intravenously and are typically prescribed in combination with other immunosuppressive medications to provide a more complete and effective immunosuppression regimen for transplant patients. Patients on the waiting list vs. Liver organ transplants conducted in 2021 were 90,483 out of 25,498 transplants performed, According to the Organ Procurement and Transplantation Network Data.The report titled “North America Kidney Transplant Market & Number, Forecast by Types (Deceased donor transplant, and living donor transplant), Drugs (Calcineurin inhibitors, Antiproliferative agents, mTor inhibitor, Steroids, and Antibodies), Region (United States, Canada, and Mexico)” studies the North America Kidney Transplant Industry.
Type - Kidney Transplant Market breakup from 3 viewpoints:
1. Deceased Donor Transplant2. Living Donor Transplant
Drugs - Kidney Transplant Market breakup from 4 viewpoints
1. Calcineurin inhibitors2. Antiproliferative agents
3. mTor inhibitor
4. Steroids
5. Antibodies
Region - Kidney Transplant Market breakup from 3 Regions:
1. United States2. Canada
3. Mexico
Table of Contents
1. Introduction2. Research & Methodology
3. Executive Summary
4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges
5. North America Kidney Transplant Number and Market
5.1 Kidney Transplant Number
5.2 Kidney Transplant Market
6. Share Analysis - North America Kidney Transplant Market
6.1 North America (United States, Mexico & Canada) - Kidney Transplant Number Share
6.2 North America (United States, Mexico & Canada) - Kidney Transplant Market Share
6.3 By Types Market Share
6.4 By Drugs Market Share
7. United States - Kidney Transplant Number and Market
7.1 United States - Kidney Transplant Number
7.2 United States - Kidney Transplant Market
8. Canada - Kidney Transplant Number and Market
8.1 Canada - Kidney Transplant Number
8.2 Canada - Kidney Transplant Market
9. Mexico - Kidney Transplant Number and Market
9.1 Mexico - Kidney Transplant Number
9.2 Mexico - Kidney Transplant Market
10. Types - Kidney Transplant Market
10.1 Deceased Donor Transplant
10.2 Living Donor Transplant
11. Drugs - Kidney Transplant Market
11.1 Calcineurin Inhibitors
11.2 Antiproliferative Agents
11.3 mTOR Inhibitor
11.4 Steroids
11.5 Antibodies
12. Company Analysis
12.1 Sanofi
12.1.1 Overview
12.1.2 Resent Development
12.1.3 Revenue
12.2 Pfizer, Inc.
12.2.1 Overview
12.2.2 Resent Development
12.2.3 Revenue
12.3 Novartis AG.
12.3.1 Overview
12.3.2 Resent Development
12.3.3 Revenue
12.4 B.Braun MelsungenAG
12.4.1 Overview
12.4.2 Resent Development
12.4.3 Revenue
12.5 Fresenius Medical Care
12.5.1 Overview
12.5.2 Resent Development
12.5.3 Revenue
12.6 Medtronic Plc
12.6.1 Overview
12.6.2 Resent Development
12.6.3 Revenue
12.7 TransMedics GroupInc
12.7.1 Overview
12.7.2 Resent Development
12.7.3 Revenue
12.8 Astellas Pharma Inc
12.8.1 Overview
12.8.2 Resent Development
12.8.3 Revenue
List of Figures:
Figure 01: North America - Kidney Transplant Market (Billion US$), 2017 - 2021
Figure 02: North America - Forecast for Kidney Transplant Market (Billion US$), 2022 - 2027
Figure 03: North America - Kidney Transplant Volume (Number), 2017 - 2021
Figure 04: North America - Forecast for Kidney Transplant Volume (Number), 2022 - 2027
Figure 05: United States - Kidney Transplant Market (Billion US$), 2017 - 2021
Figure 06: United States - Forecast for Kidney Transplant Market (Billion US$), 2022 - 2027
Figure 07: United States - Kidney Transplant Volume (Number), 2017 - 2021
Figure 08: United States - Forecast for Kidney Transplant Volume (Number), 2022 - 2027
Figure 09: Canada - Kidney Transplant Market (Million US$), 2017 - 2021
Figure 10: Canada - Forecast for Kidney Transplant Market (Million US$), 2022 - 2027
Figure 11: Canada - Kidney Transplant Volume (Number), 2017 - 2021
Figure 12: Canada - Forecast for Kidney Transplant Volume (Number), 2022 - 2027
Figure 13: Mexico - Kidney Transplant Market (Million US$), 2017 - 2021
Figure 14: Mexico - Forecast for Kidney Transplant Market (Million US$), 2022 - 2027
Figure 15: Mexico - Kidney Transplant Volume (Number), 2017 - 2021
Figure 16: Mexico - Forecast for Kidney Transplant Volume (Number), 2022 - 2027
Figure 17: Deceased Donor Transplant - Kidney Transplant Market (Million US$), 2017 - 2021
Figure 18: Deceased Donor Transplant - Forecast for Kidney Transplant Market (Million US$), 2022 - 2027
Figure 19: Living Donor Transplant - Kidney Transplant Market (Million US$), 2017 - 2021
Figure 20: Living Donor Transplant - Forecast for Kidney Transplant Market (Million US$), 2022 - 2027
Figure 21: Calcineurin Inhibitors - Kidney Transplant Market (Million US$), 2017 - 2021
Figure 22: Calcineurin Inhibitors - Forecast for Kidney Transplant Market (Million US$), 2022 - 2027
Figure 23: Antiproliferative Agents - Kidney Transplant Market (Million US$), 2017 - 2021
Figure 24: Antiproliferative Agents - Forecast for Kidney Transplant Market (Million US$), 2022 - 2027
Figure 25: mTOR Inhibitor - Kidney Transplant Market (Million US$), 2017 - 2021
Figure 26: mTOR Inhibitor - Forecast for Kidney Transplant Market (Million US$), 2022 - 2027
Figure 27: Steroids - Kidney Transplant Market (Million US$), 2017 - 2021
Figure 28: Steroids - Forecast for Kidney Transplant Market (Million US$), 2022 - 2027
Figure 29: Antibodies - Kidney Transplant Market (Million US$), 2017 - 2021
Figure 30: Antibodies - Forecast for Kidney Transplant Market (Million US$), 2022 - 2027
Figure 31: Sanofi - Global Revenue (Billion US$), 2017 - 2021
Figure 32: Sanofi - Forecast for Global Revenue (Billion US$), 2022 - 2027
Figure 33: Pfizer, Inc. - Global Revenue (Billion US$), 2017 - 2021
Figure 34: Pfizer, Inc. - Forecast for Global Revenue (Billion US$), 2022 - 2027
Figure 35: Novartis AG. - Global Revenue (Billion US$), 2017 - 2021
Figure 36: Novartis AG. - Forecast for Global Revenue (Billion US$), 2022 - 2027
Figure 37: B.Braun MelsungenAG - Global Revenue (Billion US$), 2017 - 2021
Figure 38: B.Braun MelsungenAG - Forecast for Global Revenue (Billion US$), 2022 - 2027
Figure 39: Fresenius Medical Care - Global Revenue (Billion US$), 2017 - 2021
Figure 40: Fresenius Medical Care - Forecast for Global Revenue (Billion US$), 2022 - 2027
Figure 41: Medtronic Plc - Global Revenue (Billion US$), 2017 - 2021
Figure 42: Medtronic Plc - Forecast for Global Revenue (Billion US$), 2022 - 2027
Figure 43: Trans Medics GroupInc - Global Revenue (Billion US$), 2017 - 2021
Figure 44: Trans Medics GroupInc - Forecast for Global Revenue (Billion US$), 2022 - 2027
Figure 45: Astellas Pharma Inc - Global Revenue (Billion US$), 2017 - 2021
Figure 46: Astellas Pharma Inc - Forecast for Global Revenue (Billion US$), 2022 - 2027
List of Tables:
Table 01: North America - Kidney Transplant Market Share by Countries (Percent), 2017 - 2021
Table 02: North America - Forecast for Kidney Transplant Market Share by Countries (Percent), 2022 - 2027
Table 03: North America - Kidney Transplant Volume Share by Countries (Percent), 2017 - 2021
Table 04: North America - Forecast for Kidney Transplant Volume Share by Countries (Percent), 2022 - 2027
Table 05: North America - Kidney Transplant Market Share by Type (Percent), 2017 - 2021
Table 06: North America - Forecast for Kidney Transplant Market Share by Type (Percent), 2022 - 2027
Table 07: North America - Kidney Transplant Market Share by Drugs (Percent), 2017 - 2021
Table 08: North America - Forecast for Kidney Transplant Market Share by Drugs (Percent), 2022 - 2027
Methodology
In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.
Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.
Primary Research
The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:
- Validates and improves the data quality and strengthens research proceeds
- Further develop the analyst team’s market understanding and expertise
- Supplies authentic information about market size, share, growth, and forecast
The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:
- Chief executives and VPs of leading corporations specific to the industry
- Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
- Key opinion leaders (KOLs)
Secondary Research
The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Patent and regulatory databases for understanding of technical & legal developments
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic new articles, webcasts, and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 120 |
| Published | February 2023 |
| Forecast Period | 2022 - 2027 |
| Estimated Market Value ( USD | $ 11.36 Billion |
| Forecasted Market Value ( USD | $ 14.76 Billion |
| Compound Annual Growth Rate | 5.3% |
| Regions Covered | North America |
